ID	Description	Ontology/database ID	Ontology Label	Notes	Synonym needed?	New term request	Parent	Parent ID1	5FU-based adjuvant therapy	DB00544	Fluorouracil					2	ado-trastuzumab emtansine	DB05773	ado-trastuzumab emtansine					3	afatinib	CHEBI:61390	afatinib					4	afatinib + cetuximab	DB08916; DB00002	Afatinib; Cetuximab					5	AKT inhibitors			"there are specific Akt inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound?term=akt+inihibitor"				6	ALK inhibitors			"there are specific ALK inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=ALK+inhibitor"				7	ALK inhibitors + IGF1R inhibitors			there is CHEBI:75252: insulin-like growth factor receptor 1 antagonist				8	allosteric AKT inhibitors							9	anthracyclines	CHEBI:48120	anthracycline					10	anti-EGFR mAbs			nothing in Uniprot				11	anti-EGFR mAbs + anti-HER2 mAbs			nothing in Uniprot				12	anti-EGFR mAbs + MEK inhibitors	CHEBI:79091	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor	do not have an ID for the anti-EGFR mAbs				13	anti-estrogens			nothing in Uniprot				14	anti-HER3 mAbs			nothing in Uniprot				15	anti-tubulin agents			nothing in Uniprot				16	AR antagonist			do not know what AR stands for				17	ARN-509	PubChem CID:24872560	ARN-509					18	aromatase inhhibitors	CHEBI:50790	EC 1.14.14.14 (aromatase) inhibitor					19	aspirin in adjuvant setting	DB00945	Acetylsalicylic acid					20	ATP-competitive AKT inhibitors							21	ATRA	DB00755	Tretinoin					22	ATRA + arsenic trioxide	DB00755; DB01169	Tretinoin; Arsenic trioxide					23	AURK inhibitors							24	AURK inhibitors + BCR-ABL1 inhibitors			"there are specific BCR-ABL1 inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=BCR-ABL1+inhibitor"				25	BCL2 inhibitors							26	BET inhibitors							27	BET inhibitors in LKB1 wt							28	bevacizumab	DB00112	Bevacizumab					29	bicalutamide	DB01128	Bicalutamide					30	bortezomib	DB00188	Bortezomib					31	bosutinib	DB06616	Bosutinib					32	BRAF + MEK inhibitors							33	BRAF inhibitors	PubChem CID:53438230; CHEBI:79091	BRAF inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor					34	BRAF inhibitors + CDK2/4 inhibitors	PubChem CID:53438230; n/a	BRAF inhibitor; n/a					35	BRAF inhibitors + EGFR inhibitors	PubChem CID:53438230; PubChem CID:9549299	BRAF inhibitor; EGFR Inhibitor					36	BRAF inhibitors + HSP90 inhibitors	PubChem CID:53438230; CHEBI:63962	BRAF inhibitor; Hsp90 inhibitor					37	BRAF inhibitors + MEK inhibitors	PubChem CID:53438230; CHEBI:79091	BRAF inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor					38	BRAF inhibitors + PI3K pathway inhibitors	PubChem CID:53438230; n/a	BRAF inhibitor; n/a	"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				39	BRAF inhibitors +/- MEK inhibitors	PubChem CID:53438230; CHEBI:79091	BRAF inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor	this is the same as #37				40	BRAF inhibitors in BRAF mutant tumor							41	BRAF inhibitors in BRAF mutant tumors							42	cabozantinib	DB08875	Cabozantinib					43	CDK2 inhibitors							44	CDK2/4 inhibitors	PubChem CID:16760362	cdk2/5 inhibitor				PubChem CID: 10366136	45	CDK4/6 inhibitors							46	ceritinib	CHEBI:78432	ceritinib					47	cetuximab	DB00002 	Cetuximab					48	cetuximab plus sirolimus	DB00002; DB00877	Cetuximab; Sirolimus					49	cisplatin	DB00515	Cisplatin					50	crenolanib	PubChem CID:10366136	Crenolanib					51	crizotinib	DB08865	Crizotinib					52	dabrafenib	DB08912	Dabrafenib					53	dabrafenib + trametinib	DB08912; DB08911	Dabrafenib; Trametinib					54	dasatinib	DB01254	Dasatinib					55	dasatinib + erlotinib	DB01254; DB00530 	Dasatinib; Erlotinib					56	daunorubicin	DB00694	Daunorubicin					57	DNA-PK inhibitors			"there are specific DNA-PK inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=DNA-PK+inhibitors"				58	DOT1L inhibitors							59	dovitinib	DB05928	CHIR-258					60	EGFR TKIs			"is this the same as: PubChem CID:9549299, EGFR Inhibitor?"				61	EGFR TKIs + MEK inhibitors	n/a; CHEBI:79091	n/a; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor					62	enzalutamide	DB08899	Enzalutamide					63	EPHA3 inhibitors							64	ERBB2 TKIs							65	ERK inhibitors	PubChem CID:16760416	Erk Inhibitor					66	erlotinib	DB00530	Erlotinib					67	everolimus	DB01590	Everolimus					68	EZH2 inhibitor	PubChem CID:68210102	GSK126					69	FAK inhibitors							70	FGFR inhibitors							71	FLT3 inhibitors							72	flutamide	DB00499  	Flutamide					73	Gamma secretase inhibitors							74	Gamma secretase inhibitors + CDK4 inhibitors	n/a; PubChem CID:5330797	n/a; Cdk4 Inhibitor					75	Gamma secretase inhibitors + mTOR inhibitors							76	gefitinib	DB00317	Gefitinib					77	gemcitabine + MEK inhibitors	CHEBI:175901; CHEBI:79091	gemcitabine; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor					78	HDAC inhibitors	PubChem CID:10460379	(S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide; 660847-06-3					79	HSP90 inhibitors	CHEBI:63962	Hsp90 inhibitor					80	ibrutinib	CHEBI:76612	ibrutinib					81	IDH inhibitors							82	IGF1R inhibitors	CAS 477-47-4	IGF-1R Inhibitor					83	imatinib	DB00619 	Imatinib					84	irinotecan plus CHK1/2 inhibitor in ATM deficient tumor							85	irreversible EGFR TKIs							86	JAK inhibitors	PubChem CID:5494425	Pyridone 6					87	lapatinib	DB01259	Lapatinib					88	lestaurtinib	PubChem CID:126565	Lestaurtinib					89	liposomal doxorubicin							90	MDM2 inhibitors							91	MEK inhibitors	CHEBI:79091	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor					92	MEK inhibitors + BCL-XL inhibitors	CHEBI:79091; n/a	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; n/a					93	MEK inhibitors + CDK4/6 inhibitors	CHEBI:79091; n/a	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; n/a					94	MEK inhibitors + docetaxel in KRAS mutant	CHEBI:79091; n/a	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; n/a					95	MEK inhibitors + IGF1R inhibitors	CHEBI:79091; CAS 477-47-4	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; IGF-1R Inhibitor					96	MEK inhibitors + PI3K pathway inhibitors	CHEBI:79091; n/a	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; n/a	"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				97	MEK inhibitors +/- mTOR inhibitors	CHEBI:79091; CHEBI:68481	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; mTOR inhibitor					98	MEK inhibitors +/- PI3K pathway inhibitors	CHEBI:79091; n/a	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; n/a	"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				99	MET inhibitors							100	midostaurin	CHEBI:63452	midostaurin					101	Mitomycin C	DB00305	Mitomycin					102	mTOR inhibitors	CHEBI:68481	mTOR inhibitor					103	mTOR inhibitors + BH3 mimetics							104	mTOR inhibitors + HSP90 inhibitors	CHEBI:68481; CHEBI:63962	mTOR inhibitor; Hsp90 inhibitor					105	neratinib	CHEBI:61397	neratinib					106	neratinib + temsirolimus	CHEBI:61397; CHEBI:79699	neratinib; Temsirolimus					107	nilotinib	DB04868	Nilotinib					108	PAK inhibitors							109	panitumumab	DB01269	Panitumumab					110	PARP inhibitors	PubChem CID:78243706	"ABT-888, PARP Inhibitor"					111	PARP inhibitors + chemotherapy	PubChem CID:78243706; n/a	"ABT-888, PARP Inhibitor; n/a"					112	pazopanib	PubChem CID:10113978	Pazopanib					113	PDGFR inhibitors							114	PDL1 inhibitors							115	pertuzumab	DB06366	Pertuzumab					116	phenformin	DB00914	Phenformin					117	PI3K alpha inhibitors							118	PI3K beta inhibitors							119	PI3K pathway inhibitors			"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				120	PI3K pathway inhibitors + AR antagonists			"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				121	PI3K pathway inhibitors + MEK inhibitor			"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				122	PI3K pathway inhibitors + MEK inhibitors			"there are specific PI3K inhibitors in pubchem, but nothing general: https://www.ncbi.nlm.nih.gov/pccompound/?term=PI3K+inhibitor"				123	PKC inhibitor	CHEBI:37700	EC 2.7.11.13 (protein kinase C) inhibitor					124	PKC412	CHEBI:63452	midostaurin					125	platinum agents	CHEBI:33364	platinum	not sure if this is correct?				126	ponatinib	DB08901	Ponatinib					127	proteosome inhibitors							128	quizartinib	PubChem CID:24889392	Quizartinib					129	rapamycin	DB00877	Sirolimus					130	regorafenib	DB08896	Regorafenib					131	RET inhibitors							132	ruxolitinib	DB08877	Ruxolitinib					133	selumetinib	PubChem CID:10127622	Selumetinib					134	sirolimus	DB00877 	Sirolimus					135	sorafenib	DB00398 	Sorafenib					136	sorafenib + azacytidine	DB00398; DB00928 	Sorafenib; Azacitidine					137	SRC inhibitors	CHEBI:78332	Src Inhibitor-1	not sure if this is correct?				138	steroids	CHEBI:35341	steroid					139	sunitinib	DB01268	Sunitinib					140	SYK inhibitors	PubChem CID:6419747	Syk Inhibitor					141	tankyrase inhibitors	CHEBI:62887	tankyrase inhibitor					142	temozolomide	DB00853 	Temozolomide					143	trametinib	DB08911	Trametinib					144	trastuzumab	DB00072	Trastuzumab					145	trastuzumab + everolimus + chemotherapy	DB00072; CHEBI:68478; n/a	Trastuzumab; everolimus; n/a					146	trastuzumab + HSP90 inhibitors	DB00072; CHEBI:63962	Trastuzumab; Hsp90 inhibitor					147	trastuzumab + PI3K pathway inhibitors	DB00072; n/a	Trastuzumab; n/a					148	TRK inhibitors							149	vandetanib	DB05294	Vandetanib					150	VEGFR inhibitors							151	vemurafenib	DB08881	Vemurafenib					152	vismodegib	DB08828	Vismodegib					153	wee1 inhibitors	PubChem CID:10384072	Wee1 Inhibitor					256	encorafenib + cetuximab	PubChem CID:50922675;  DB00002	LGX-818; Cetuximab					257	vemurafenib + panitumumab	DB08881; DB01269	Vemurafenib; Panitumumab					258	vemurafenib + cetuximab	DB08881; DB00002	Vemurafenib; Cetuximab					259	E6201	PubChem CID:10172827	UNII-CZP9GB25HO					260	binimetinib	PubChem CID:10288191	MEK162					261	LEE011	PubChem CID:44631912	LEE-011					262	binimetinib + LEE011	PubChem CID:10288191; PubChem CID:44631912	MEK162; LEE-011					263	cobemetinib	PubChem CID:16222096	Cobimetinib					264	AEB071	PubChem CID:10296883	Sotrastaurin					265	BYL719	PubChem CID:56649450	BYL-719					266	AEB071 + BYL719	PubChem CID:10296883; PubChem CID:56649450	Sotrastaurin; BYL-719					267	alectinib	PubChem CID:49806720	Alectinib					268	TAE684	PubChem CID:16038120	NVP-TAE684					269	AMG-337							